NYSE (USA) TSX (CANADA)

Directory of Stock Market Company

This site is a directory of Stock Market Company in USA and Canada. Each company page contains a description, stock quote, news and much more. You have also access to the best stock market game on the web.

Search into NYSE and TSX
by quote, company name or key word

facebooktwitterlinkedin
Mail

AMRN - Amarin Corp PLC

Amarin Corporation plc (Amarin), incorporated on March 1, 1989, is a clinical-stage biopharmaceutical company focused on developing improved treatments for cardiovascular disease. The Company’s development programs capitalize in the field of lipid science and the therapeutic benefits of essential fatty acids in cardiovascular disease. It is focusing its efforts on its lead candid","NYSE, Nasdaq, S&P, trading, US market, Asian market, Dow Jones, FTSE, DJIA, DAX, stocks, bonds, shares","Connect to the most current information on stocks and bonds on Reuters.com. What you need to know now about NYSE, Dow Jones, S&P, and Nasdaq at Reuters.com"

# AMRNhart

Amarin Corp PLC News


Brief Review Of A Few Biotechs
Seeking Alpha - 15 hours ago
The following is a review of three biotech stocks with potential for growth. Amarin (AMRN), Osiris (OSIR and Abbott (ABT) are three companies with either recent breakthroughs, a catalyst, or a possible place to ride out a coming storm.

Travel Arm Of Expedia Inc. Launched Next Phase Of Egencia Mobile (EXPE, SHLD ...
Galaxy Stocks - 21 hours ago
Expedia Inc. (NASDAQ:EXPE) Egencia(R), the corporate travel arm of Expedia Inc., recently launched the next phase of Egencia Mobile, extending their mobile application to Android and Mobile Web devices.

Amarin: May 16 Patent Updates - What Do They Mean?
Seeking Alpha - May 18, 2012
On May 16, 2012, Amarin Corp (AMRN) submitted its "Response to Non-Final Office Action Dated March 2, 2012" to the United States Patent and Trademark Office.

Analyst Alerts: Amarin, E Commerce China, Bed Bath & Beyond, GameStop, Wal ...
Wall St. Cheat Sheet - May 17, 2012
By Derek Hoffman Amarin Corporation plc (NASDAQ:AMRN): After Amarin submitted amended claims and two more declarations to the US Patent Office , Leerink believes that the conclusion of the company's patent attorney sounds encouraging.

Healthcare Sectors Showed Positive Momentum- OREX, ARNA, VVUS, DVAX, TEVA ...
eStocksDaily - May 14, 2012
Orexigen Therapeutics, Inc. (NASDAQ:OREX) diet-drug developer, jumped 20 percent to $4.03 on Friday in the wake of news that an advisory panel of the US Food and Drug Administration has suggested authorization of Arena Pharmaceuticals, ...

Amarin: Most Undervalued Name In Biotech?
Seeking Alpha - May 13, 2012
Before I dig into the article, I just wanted to express my thanks to the SA community, as I have been an avid reader for quite some time of many in the healthcare sector.

Canaccord Genuity Reaffirms Buy Rating on Amarin Co. plc (AMRN)
Movie News Guide (blog) - May 10, 2012
Amarin Co. plc (NASDAQ: AMRN)'s stock had its “buy” rating restated by equities researchers at Canaccord Genuity in a report issued on Wednesday.

Canaccord Genuity Reiterates a 'Buy' on Amarin Corporation (AMRN); Next Stop ...
StreetInsider.com (subscription) - May 9, 2012
Analyst, Ritu Baral, said, "Reiterate rating and price target on commercial, partnership potential of AMR101. We think AMR101, Amarin's 96% EPA omega-3 for high triglycerides, will be approved for hypertriglyceridemia in H2/12, likely around its July ...

Amarin Slips To Loss In Q1 -Quick Facts
NASDAQ - May 8, 2012
(RTTNews.com) - Amarin Corp. (AMRN) reported a first-quarter net loss of $88.3 million or $0.65 per share, compared to a net income of $18.3 million or $0.12 per share last year in the same period.

Amarin Reports First Quarter 2012 Financial Results and Provides Update on ...
MarketWatch (press release) - May 8, 2012
BEDMINSTER, NJ, and DUBLIN, Ireland, May 8, 2012 (GlobeNewswire via COMTEX) -- Amarin Corporation plc (NASDAQ:AMRN) , a late-stage biopharmaceutical company focused on cardiovascular disease, today announced financial results for the quarter ended ...

NYSE Media Coverage Selection of the best articles found in your favorit medias

Next Company >>